DUBLIN, March 11, 2019 /PRNewswire/ -- The "Live Cell Imaging Market by Product (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Drug Discovery), End User (Pharmaceutical & Biotechnology Companies, Research Institutes) - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering.

The live cell imaging market is expected to reach USD 2.9 billion by 2023 from an estimated USD 1.9 billion in 2018, at a CAGR of 8.9% during the forecast period.

Live cell imaging is an important analytical tool used to study living cells. Imaging systems such as microscopes and high-content screening systems are used in live cell imaging.

These techniques are becoming an integral part of a wide range of applications, such as cell biology, neurobiology, pharmacology, developmental biology, and drug discovery. Unlike other techniques that provide details on the current state of cells, live cell imaging helps in investigating the dynamic processes in living cells.

The growing adoption of high-content screening techniques in drug discovery, rising incidence of cancer, and the growth in funding for research are the major factors driving the growth of the global live cell imaging market.

However, factors such as the high cost of high-content screening systems and the shortage of skilled professionals are expected to restrain the growth of this market during the forecast period.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Live Cell Imaging: Market Overview
4.2 Live Cell Imaging Market, By Product and Service, 2018
4.3 Live Cell Imaging Market, By Application, 2018
4.4 Live Cell Imaging Market: Geographic Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Adoption of High-Content Screening Techniques in Drug Discovery
5.2.1.2 Rising Incidence of Cancer
5.2.1.3 Growing Availability of Funds for Research
5.2.2 Restraints
5.2.2.1 High Cost of High-Content Screening Systems
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Application of HCS in Personalized Medicine
5.2.4 Challenges
5.2.4.1 Maintaining Cell Viability & Cellular Environment in the Culture
5.2.4.2 Dearth of Skilled Professionals

6 Live Cell Imaging Market, By Product & Service
6.1 Introduction
6.2 Instruments
6.2.1 Increasing Demand for Live Cells for Analysis in the Biotechnology and Biopharmaceutical Industries to Drive the Adoption of Live Cell Imaging Instruments
6.2.2 Microscopes
6.2.3 Standalone Systems
6.2.4 Cell Analyzers
6.2.5 Accessories
6.3 Consumables
6.3.1 Reagents
6.3.1.1 Reagents Segment to Account for the Largest Share of the Live Cell Imaging Consumables Market in 2018
6.3.2 Assay Kits
6.3.2.1 Repeat Purchase of Assay Kits - Key Driver for Market Growth
6.3.3 Media
6.3.3.1 Development of New and Advanced Technologies has Resulted in an Increased Demand for High-Quality Media in Biomedical Research and Processing
6.3.4 Other Consumables
6.4 Software
6.4.1 Technological Advancements in Image Acquisition - A Key Driver for Market Growth
6.5 Services
6.5.1 Availability of A Wide Range of Services and Growing Number of Initiatives By Key Players to Drive the Services Market

7 Live Cell Imaging Market, By Application
7.1 Introduction
7.2 Cell Biology
7.2.1 Increasing Prevalence of Cancer to Drive the Cell Biology Application Segment
7.3 Stem Cells
7.3.1 Importance of Stem Cell Research has Boosted Investments in This Area
7.4 Developmental Biology
7.4.1 Growing Research in Developmental Biology A Key Driver of Market Growth
7.5 Drug Discovery
7.5.1 Use of HCS Cell-Based Assays has Grown in Drug Development Studies

8 Live Cell Imaging Market, By End User
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Increasing R&D Activities and the Patent Cliff of Various Blockbuster Drugs to Increase the Demand for Live Cell Imaging Products in Pharmaceutical and Biotechnology Companies
8.3 Academic & Research Institutes
8.3.1 Demand for Live Cell Imaging Products to Increase in Academic and Research Institutes Owing to the Rising Focus of These End Users on Strengthening Their Own Drug Discovery Research Programs
8.4 Contract Research Organizations
8.4.1 Growing Outsourcing of R&D Activities By Pharmaceutical Companies to Drive the Demand for Live Cell Imaging Systems in Contract Research Organizations

9 Live Cell Imaging Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the North American Live Cell Imaging Market Primarily Due to the Strong Trend of Pharmaceutical & Biotechnology Research and the High Burden of Cancer
9.2.2 Canada
9.2.2.1 Government Initiatives to Promote Research and the Need to Combat Cancer are the Key Factors Driving the Growth of the Live Cell Imaging Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Presence of A Large Number of Academic Research Institutes and Increasing R&D Spending to Drive the Demand for Live Cell Imaging in Germany
9.3.2 UK
9.3.2.1 UK has Seen A Surge in the Prevalence of Cancer; By 2030, an Estimated 4 Million People are Expected to Be Diagnosed With the Disease
9.3.3 France
9.3.3.1 Growth in the French Live Cell Imaging Market is Attributed to the Large Pharmaceutical Manufacturing Industry and the High Public Expenditure on R&D in France
9.3.4 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 China
9.4.1.1 China to Register the Highest Growth Rate in the Asia Pacific Live Cell Imaging Market During the Forecast Period
9.4.2 Japan
9.4.2.1 Increasing Aging Population, Rising Prominence for Regenerative Medicine Research, and Increasing Number of Researchers to Support Market Growth in Japan
9.4.3 India
9.4.3.1 Favorable Changes in Foreign Direct Investment (FDI) Regulations in the Pharmaceutical Industry to Drive Market Growth
9.4.4 RoAPAC
9.5 RoW

10 Competitive Landscape
10.1 Introduction
10.2 Live Cell Imaging Market Share Analysis (2017)
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.2 Innovators
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Scenario

11 Company Profiles
11.1 Danaher Corporation
11.2 Carl Zeiss AG
11.3 Nikon Corporation
11.4 Olympus Corporation
11.5 Perkinelmer
11.6 GE Healthcare
11.7 Bruker
11.8 Thermo Fisher Scientific
11.9 Sartorius AG
11.10 Biotek Instruments
11.11 Etaluma
11.12 Cytosmart Technologies
11.13 Nanoentek

For more information about this report visit https://www.researchandmarkets.com/research/6ms4f4/live_cell_imaging?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com